Pancreatic Diseases – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Pancreatic Diseases – Drugs In Development, 2024 report and make more profitable business decisions.
Pancreatic diseases encompass a range of conditions that affect the pancreas, a vital organ located behind the stomach. The pancreas plays a crucial role in digestion and hormone regulation by producing enzymes for digestion and hormones like insulin and glucagon that regulate blood sugar levels.
The Pancreatic Diseases drugs in development market research report provide comprehensive information on the therapeutics under development for Pancreatic Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pancreatic Diseases and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Pancreatic Diseases | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 52 molecules, with 46 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Pancreatic Diseases therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Pancreatic Diseases pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Pancreatic Diseases treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AcelRx Pharmaceuticals IncAnagram Therapeutics Inc
Ariel Precision Medicine Inc
Baylor Scott & White Health
Beijing GeneCradle Technology Co Ltd
Bessor Pharma LLC
BioHybrid Solutions LLC
CalciMedica Inc
Centeer BioTherapeutics Ltd Co
ChemIcare Srl
Cilian AG
Cisen Pharmaceutical Co Ltd
Cypralis Ltd
D&D Pharmatech Co Ltd
Daewoong Pharmaceutical Co Ltd
DiaMedica Therapeutics Inc
Duke University
Duke University Medical Center
Elicio Therapeutics Inc
Eneapharm
Evive Biotech
First Wave BioPharma Inc
Georgetown University
GNT Pharma Co Ltd
GSK plc
Healx Ltd
HighTide Therapeutics Inc
JD Bioscience Inc
Kynos Therapeutics Ltd
Lamassu Pharma LLC
LipimetiX Development Inc
LyGenesis Inc
Mallinckrodt Plc
Merck & Co Inc
OM Pharma Ltd
Panbela Therapeutics Inc
Path BioAnalytics Inc
Perseo Pharma AG
PNB Vesper Life Science Pvt Ltd
Samsung Bioepis Co Ltd
SCM lifescience Co Ltd
Shionogi & Co Ltd
University Hospital Geneva
University of Barcelona
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Pancreatic Diseases reports